|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China显示文摘INTRODUCTIONAdenocarcinomas of the cardia are the lesionsarising from the proximal stomach or within 3 cm ofthe gastroesophageal junction.These cancerstended to be advanced at the time of presentation,usually with poor prognosis.In recent decade,the incidence of adenocarcinoma of gastric eardiaand esophagus are increasing steadily,while therehas been a decrease in the proportion of the cancersarising from the distal stomach.The | Naoko lida Hideaki Oda Shigetoshi Aiso Takatoshi Ishikawa | 2000 | World Journal of Gastroenterology2000，6，5： | 17 |
| 2 | Hepatitis B virus reactivation associated with antirheumatic therapy: risk and prophylaxis recommendations显示文摘Accompanying the increased use of biological and non-biological antirheumatic drugs,a greater number of cases of hepatitis B virus(HBV) reactivation have been reported in inactive hepatitis B surface antigen(HBs Ag) carriers and also in HBs Ag-negative patients who have resolved HBV infection. The prevalence of resolved infection varies in rheumatic disease patients,ranging from 7.3% to 66%. Through an electronic search of the Pub Med database,we found that among 712 patients with resolved infection in 17 observational cohort studies,12 experienced HBV reactivation(1.7%) during biological antirheumatic therapy. Reactivation rates were 2.4% for etanercept therapy,0.6% for adalimumab,0% for infliximab,8.6% for tocilizumab,and 3.3% for rituximab. Regarding non-biological antirheumatic drugs,HBV reactivation was observed in 10 out of 327 patients with resolved infection from five cohort studies(3.2%). Most of these patients received steroids concomitantly. Outcomes were favorable in rheumatic disease patients. A number of recommendations have been established,but most of the supporting evidence was derived from the oncology and transplantation fields. Compared with patients in these fields,rheumatic disease patients continue treatment with multiple immunosuppressants for longer periods. Optimal frequency and duration of HBV-DNA monitoring and reliable markers for discontinuation of nucleoside analogues should be clarified for rheumatic disease patients with resolved HBV infection. | Shunsuke Mori Shigetoshi Fujiyama | 2015 | World Journal of Gastroenterology2015，21，36： | 9 |
| 3 | Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo显示文摘 | Masahiko Kurokawa Kazuhiko Nagasaka Tatsuji Hirabayashi Shin-ichi Uyama Hideki Sato Takashi Kageyama Shigetoshi Kadota Haruo Ohyama Toyoharu Hozumi Tsuneo Namba Kimiyasu Shiraki | 1995 | Antiviral Research1995，，1： | 3 |
| 4 | Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma显示文摘Intrahepatic cholangiocarcinoma is macroscopically classified into three subtypes, mass-forming-type, periductal infiltrating-type, and intraductal growth-type. Each subtype should be preoperatively differentiated to perform the valid surgical resection. Recent researches have revealed the clinical, radiologic, pathobiological characteristics of each subtype. We reviewed recently published studies covering various aspects of intrahepatic cholangiocarcinoma(ICC), focusing especially on the macroscopic subtypes and stem cell features to better understand the pathophysiology of ICC and to establish the valid therapeutic strategy. | Yuichi Sanada Yujo Kawashita Satomi Okada Takashi Azuma Shigetoshi Matsuo | 2014 | World Journal of Gastrointestinal Pathophysiology2014，5，3： | 3 |
| 5 | Rapid nondestructive screening for melamine in dried milk by Raman spectroscopy显示文摘 | Shigetoshi Okazaki Mitsuo Hiramatsu Kunio Gonmori Osamu Suzuki Anthony T. Tu | 2009 | Forensic Toxicology2009，，2： | 2 |
| 6 | Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma显示文摘 | Takuji Okusaka Shuichi Okada Toshio Nakanishi Shigetoshi Fujiyama Yasuhiko Kubo | 2004 | Investigational New Drugs2004，，2： | 2 |
| 7 | Tribulusamide A and B, New Hepatoprotective Lignanamides from the Fruits of Tribulus terrestris: Indications of Cytoprotective Activity in Murine Hepatocyte Culture显示文摘 | Jian-Xin Li Qin Shi Quan-Bo Xiong Jeevan Prasain Yasuhiro Tezuka Toru Hareyama Zheng-Tao Wang Ken Tanaka Tsuneo Namba Shigetoshi Kadota | 1998 | Planta Med1998，，07： | 2 |
| 8 | Skull metastasis from hepatocellular carcinoma with chronic hepatitis B显示文摘A 56-year-old male visited our hospital for evaluation of an occipital mass.Contrast computed tomography showed hypervascular enhancement with osteolytic change in the skull and a huge enhanced mass in the liver.Magnetic resonance imaging showed bone metastasis in the thoracic vertebrae.Assays for hepatitis B surface antigen and hepatitis B core antibody were positive and his liver condition was Child-Pugh grade A.Our diagnosis was hepatocellular carcinoma(HCC) with skull and vertebrae metastases on chronic hepatitis B.He was treated with radiation therapy for bone metastases and transcatheter arterial chemoembolization for HCC.But he developed acute respiratory failure because of aspiration pneumonia,congestion and oedema with haemorrhage of the lungs and died.Dissection showed HCC with multiple bone metastases.The liver tumor was categorized as well-differentiated HCC,Edmondson classification Ⅰ,trabecular type and pseudoglandular type.In the liver mild infiltration of lymphocytes was seen in Glisson's capsules which were signif icantly enlarged with well preserved limiting plates.Piecemeal necrosis was not obvious.No fibrosis was noted.An 8 cm × 7 cm × 3 cm metastatic lesion had formed in the left occipitotemporal part of the cranial bone.The lesion was osteolytic and showed invasion into the dura mater.Neither the subdural cavity nor the brain showed involvement from the metastatic tumor.However,skull metastasis from HCC is very rare and it affects the patient's prognosis and the quality of life.Therefore,it is very important to make an early diagnosis and carry out proper management of skull metastasis from HCC. | Takashi Goto Takahiro Dohmen Kouichi Miura Shigetoshi Ohshima Kazuo Yoneyama Tomomi Shibuya Ei Kataoka Daisuke Segawa Wataru Sato Yumiko Anezaki Hajime Ishii Daigo Kon Ikuhiro Yamada Kentaro Kamada Hirohide Ohnishi | 2010 | World Journal of Gastrointestinal Oncology2010，2，3： | 2 |
| 9 | Neuromuscular and skeletal adaptations following mandibular forward positioning induced by the Herbst appliance显示文摘 | Shigetoshi H | 2000 | Angle Orthod2000，70，6： | 1 |
| 10 | Evaluation of environmental burden in eco-friendly machining method u- sing life cycle assessment method-estimation of carbon dioxide emission in eeo-friendly turning method显示文摘 | SHOJIRO T SHIGETOSHI O KUNIO K | 2003 | Journal of the Ja pan Society for Precision Engineering2003，69，6： | 1 |
| 11 | Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer显示文摘 | Kazuhiro Yasufuku Takahiro Nakajima Taiki Fujiwara Masako Chiyo Akira Iyoda Shigetoshi Yoshida Makoto Suzuki Yasuo Sekine Kiyoshi Shibuya Ichiro Yoshino | 2008 | General Thoracic and Cardiovascular Surgery2008，，6： | 1 |
| 12 | Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study显示文摘 | Takumi Kawaguchi Atsumasa Komori Masataka Seike Shigetoshi Fujiyama Hiroshi Watanabe Masatoshi Tanaka Shotaro Sakisaka Makoto Nakamuta Yutaka Sasaki Makoto Oketani Toshihiro Hattori Koichi Katsura Michio Sata | 2012 | Journal of Gastroenterology2012，，12： | 1 |
| 13 | Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status显示文摘 | Shigetoshi Naito Hiroshi Imamura Akira Tukada Yutaka Matsuyama Jiro Yoshimoto Hiroyuki Sugo Yoichi Ishizaki Seiji Kawasaki | 2014 | Liver Int2014，，5： | 1 |
| 14 | Small bowel anisakiosis: A report of two cases显示文摘小肠狭窄是肠的 anisakiosis 的严肃的复杂并发症。这份报告的目的是调查小肠的严重狭窄是否能保存地被管理。我们与 anisakiosis 引起的小肠的严重狭窄对待二个病人。外科的干预最后被执行在上第 23 和第 35 在医院里分别地。 resected 标本的组织病理学说的检查表明肠的墙被 anisakiosis 的炎性反应完全损坏了,并且损坏是不可逆的,从而建议那剖腹术在严重的小肠狭窄的情况下被需要由肠的 anisakiosis 引起了,就算为肠的 anisakiosis 的保守疗法的一个长时期允许病人通过尖锐阶段成功地过去。 | Shigetoshi Matsuo Takashi Azuma Seiya Susumu Satoshi Yamaguchi Shirou Obata Tomayoshi Hayashi | 2006 | World Journal of Gastroenterology2006，12，25： | 1 |
| 15 | Carcinogenic activity of Farfugium japonicum and Senecio eannabifolius显示文摘 | Iwao Hirono Ikuko Ueno Shigetoshi Aiso | 1983 | Cancer Letters1983，20，2： | 1 |
| 16 | Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma显示文摘 | Takuji Okusaka Shuichi Okada Toshio Nakanishi Shigetoshi Fujiyama Yasuhiko Kubo | 2004 | Investigational New Drugs2004，，2： | 1 |
| 17 | Microtexture in the friction-stir weld of an aluminum alloy显示文摘 | Yutaka S. Sato Hiroyuki Kokawa Keiske Ikeda Masatoshi Enomoto Takenori Hashimoto Shigetoshi Jogan | 2001 | Metallurgical and Materials Transactions A2001，，4： | 1 |
| 18 | 显示文摘 | Shigetoshi F Motohiko T Seishi M | 2002 | Oncology2002，62，1： | 1 |
| 19 | Tumor markers in early diaguosis,follow-up and management of patients with hepatocellular carcinoma显示文摘 | Motohiko T Seishi M | 2002 | Oncol-ogy2002，62，1： | 1 |
| 20 | Precipitation sequence in friction stir weld of 6063 aluminum during aging显示文摘 | Yutaka S. Sato Hiroyuki Kokawa Masatoshi Enomoto Shigetoshi Jogan Takenori Hashimoto | 1999 | Metallurgical and Materials Transactions A1999，，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员